Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC.
Lee EJ, Oh SY, Lee YW, Kim JY, Kim MJ, Kim TH, Lee JB, Hong MH, Lim SM, Baum A, Woelflingseder L, Engelhardt H, Petronczki M, Solca F, Yun MR, Cho BC.
Lee EJ, et al. Among authors: kim jy, kim th, kim mj.
Clin Cancer Res. 2024 Apr 15;30(8):1582-1594. doi: 10.1158/1078-0432.CCR-23-2951.
Clin Cancer Res. 2024.
PMID: 38330145